08.03.15
JAPAN: Ushio Inc., Tokyo, has entered into exclusive license and research agreements for narrowband-spectrum ultraviolet light technology with Columbia University. The aim is to promote R&D and commercialization of an Ultraviolet Disinfection Method. For example, a successful product may utilize UV radiation within a particular wavelength range to prevent surgical site infection.
More than 8,000 patients in the US alone die from in-hospital infection, accounting for $3 billion to $10 billion in annual health care costs.
A team at Columbia University Medical Center has developed a disinfection system that selectively kills bacteria and viruses without damaging human cells/tissues. The system uses a narrowband-spectrum UV light to disinfect bacteria and viruses such as MRSA, influenza, MERS-CoV, SERS-CoV and Ebola.
More than 8,000 patients in the US alone die from in-hospital infection, accounting for $3 billion to $10 billion in annual health care costs.
A team at Columbia University Medical Center has developed a disinfection system that selectively kills bacteria and viruses without damaging human cells/tissues. The system uses a narrowband-spectrum UV light to disinfect bacteria and viruses such as MRSA, influenza, MERS-CoV, SERS-CoV and Ebola.